About this event

  • Date and time Fri 21 May 2021 from 1:55pm to 7:30pm
  • Location Royal Society of Medicine
  • Organised by Oncology

Join us for an update on the latest developments of immunotherapy for treating lung cancer, melanoma and renal cancer as well as to discuss some of the controversies in the field. 

You'll also hear about the latest clinical and basic research in lung cancer from young investigators/PhD students competing for the Sylvia Lawler Prize. This webinar combines learning opportunities, debating points and a competition for a national prize.

Participants will be able to:

  • Update the cancer community on the activity of immunotherapies, controversies in the area and where we are going next.
  • Award the Sylvia Lawler Prize to the best of six oral presentations from young investigators in cancer

A CPD certificate with 5 CPD credits will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording.

Oncology Section: Sylvia Lawler Prize


£250 to oral presenters

Submission deadline

12 April 2021

Open to

All clinicians in training

Application guidelines:

Abstracts of no more than 200 words are invited from clinicians in training, themed on a clinical research project.

The top 6 abstracts (3x clinical, 3x scientific) will be selected for oral presentations; a panel of judges will determine the best oral presentation and 1 applicant will be awarded the Sylvia Lawler Prize for the best scientific paper and 1 applicant will be awarded the Sylvia Lawler Prize for the best clinical paper.

Clinical research includes but is not limited to audit data, imaging studies, outcomes of surgical procedures. Translational studies such as genomic studies of clinical samples should be submitted for the basic/translational science prize. If the applicant is unsure of the appropriate prize to specify they should highlight this at the time of submission.

Submit your clinical abstract here >>

Submit your scientific abstract here >>

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place. 

Join in the conversation online #RSMLive 
Follow us on Twitter: @RoySocMed 

Key speakers

Professor Sanjay Popat

The Royal Marsden NHS Foundation Trust

Professor Christian Ottensmeier

Professor of Experimental Medicine, University of Liverpool


View the programme

Session one: Role of immunotherapy in clinical practice

Welcome and introduction
Lung cancer

Professor Sanjay Popat, The Royal Marsden NHS Foundation

Bladder cancer

Professor Robert Huddart, Institute of Cancer Research, London

Trophoblastic cancer

Professor Michael Seckl, Director of the Charing Cross Gestational Trophoblastic Disease and Malignant Ovarian Germ Cell Tumour Services, Imperial College Healthcare NHS Trust, President, Oncology Section, Royal Society of Medicine

Panel discussion
Tea and coffee break

Session two: Predicting response and managing resistance

Biological perspective

Dr Ehsan Ghorani, University College London Cancer Institute

What's wrong with existing markers?

Professor Christian Ottensmeier, Professor of Experimental Medicine, University of Liverpool

Lessons from melanoma

Dr Paul Nathan, Mount Vernon Cancer Centre

Panel discussion
Comfort break

Session three: Sylvia Lawler competition presentations

Presentation of the Sylvia Lawler Prize Clinical and Scientific

New onset diabetes after partial pancreatectomy: Development of a novel predictive model using machine learning

Dr Aditya Borakati

Risk of bowel obstruction in patients undergoing neoadjuvant chemotherapy for high-risk colon cancer: A nested case-control matched analysis of an international, multi-centre, randomised controlled trial (FOxTROT

Dr James Glasbey

Safety and efficacy of immune checkpoint inhibitors in cancer patients with pre-existing autoimmune disease: A UK tertiary cancer centre experience

Dr Grisma Patel

Immune checkpoint blockade differentially affects CD8+ T-cells as a function of their phenotype and clonal size

Dr Robert Watson

Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours

Dr Mark Lythgoe

PBX4 functions as a potential novel oncopromoter in colorectal cancer: a comprehensive analysis of the PBX gene family

Dr Eirini Martinou

Announcement of winners


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations. 

Special rates for difficult times 

The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic. 

Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.